# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-22-136867
Filing Date
2022-05-02
Accepted
2022-05-02 16:36:56
Documents
6
Period of Report
2022-06-21

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | d296110ddef14a.htm | DEF 14A | 1373769
2 | GRAPHIC | g296110g10v55.jpg | GRAPHIC | 30818
3 | GRAPHIC | g296110g11i11.jpg | GRAPHIC | 233912
4 | GRAPHIC | g296110g16f81.jpg | GRAPHIC | 24487
5 | GRAPHIC | g296110g22i22.jpg | GRAPHIC | 282644
6 | GRAPHIC | g296110g69b62.jpg | GRAPHIC | 37433
| Complete submission text file | 0001193125-22-136867.txt |  | 2208519

Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

EIN.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-14956 | Film No.: 22882557
SIC: 2834 Pharmaceutical Preparations